Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. Interactions with angiotensin II

Abstract

We have evaluated the role of connective tissue growth factor (CTGF) in vascular and renal damage associated with hypertension and possible interactions with angiotensin II (Ang II). Spontaneously hypertensive rats (SHR) were treated with either the Ang II receptor antagonist candesartan (C;2 mg/Kg^-1/day^-1) or antihypertensive triple therapy (TT; in mg/Kg-¹/day^-1 ;20 hydralazine +7 hydrochlorothiazide +0.15 reserpine) for 10 weeks. Wistar Kyoto rats were used as a normotensive control group. Hypertension was associated with an increase in aortic media area, media-to-lumen ratio and collagen density. Kidneys from SHR showed minimum renal alterations. Aorta and renal gene expression and immunostaining of CTGF were higher in SHR. Candesartan decreased arterial pressure, aortic media area, media-to-lumen ratio and collagen density. However, although arterial pressure decrease was comparable for both treatments,TT partially reduced these parameters. Candesartantreated rats showed lower levels of vascular CTGF expression, aortic media area, media-to-lumen ratio and collagen density than TT-treated animals. Treatments improve renal damage and reduce renal gene exp Pression and CTGF immunostaining in SHR in a similar manner.The results show that vascular and renal damage is associated with stimulation of CTGF gene and protein content.These results also might suggest that CTGF could be one downstream mediator of Ang II in hypertension-associated organ damage in SHR.

Keywords

fibrosis vessel kidney angiotensin CTGF

Get full access to this article

View all access options for this article.

References

Brown MJ , Haydock S. Pathoaetiology, epidemiology and diagnosis of hypertension. Drugs 2000;59 (suppl) 2:1-12; discussion 39-40.

Luft FC , Mervaala E. , Muller DN et al. Hypertensioninduced end-organ damage: A new transgenic approach to an old problem. Hypertension 1999;33:212-21.

Mensah GA , Croft JB , Giles WH The heart, kidney, and brain as target organs in hypertension. Cardiol Clin 2002;20:225-47.

Chobanian AV Pathophysiology of atherosclerosis. Am J Cardiol 1992;27;70:3G-7.

Dzau VJ Atherosclerosis and hypertension: mechanisms and interrelationships . J Cardiovasc Pharmacol 1990;15:S59—64.

Cediel E. , Sanz-Rosa D. , Oubina MP et al. Effect of AT1receptor blockade on hepatic redox status in SHR: possible relevance for endothelial function? Am J Physiol Regul Integr Comp Physiol 2003;285:R674-81.

Gibbons GH Endothelial function as a determinant of vascular function and structure: a new therapeutic target. Am J Cardiol 1997 ;79:3-8.

Panza JA , Garcia CE , Kilcoyne CM , Quyyumi AA , Cannon RO Impaired Endothelium-Dependent Vasodilation in Patients With Essential-Hypertension - Evidence That Nitric-Oxide Abnormality Is Not Localized to A Single Signal-Transduction Pathway. Circulation 1995;91:1732-8.

Dzau VJ , Gibbons GH Endothelium and growth factors in vascular remodelling of hypertension . Hypertension 1991;18:111115-21.

10.

Park JB , Schiffrin EL Effects of antihypertensive therapy on hypertensive vascular disease . Curr Hypertens Rep 2000;2:280-8.

11.

McGrath JC , Deighan C. , Briones AM et al. New aspects of vascular remodelling: the involvement of all vascular cell types. Exp Physiol 2005;90:469-75.

12.

Pauletto P. , Sarzani R. , Rappelli A. , Chiavegato A. , Pessina AC , Sartore S. Differentiation and growth of vascular smooth muscle cells in experimental hypertension. Am J Hypertens 1994;7:661-74.

13.

Whitworth JA Progression of renal failure - the role of hypertension . Ann Acad Med Singapore 2005 ;34:8-15.

14.

Ritz E. The role of the kidney in cardiovascular medicine. Eur J Intern Med 2005;16:321-7.

15.

Maschio G. , Oldrizzi L. , Marcantoni C. , Rugiu C. Hipertensión and progression of renal disease. J Nephrol 2000;13:225-7.

16.

Porush JG Hypertension and chronic renal failure: the use of ACE inhibitors . Am J Kidney Dis 1998;31:177-84.

17.

Zucchelli P. , Zuccala A. Progression of renal failure and hypertensive nephrosclerosis. Kidney Int (suppl) 1998 ;68:S55-9.

18.

Martinez-Maldonado M. Role of hypertension in the progression of chronic renal disease. Nephrol Dial Transplant 2001;16:63-6.

19.

Rodrigo E. , Maeso R. , Munoz-Garcia R. et al. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril. J Hypertens 1997;15:613-18.

20.

Schiffrin EL Park JB , Intengan HD , Touyz RM Correction of arterial structure and endothelial dysfunction in human ssential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000;101:1653-9.

21.

Sanz-Rosa D. , MP Oubiña , Cediel E. et al. Effect of AT1Preceptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kB/IkB system. Am J Physiol Heart Circ Physiol 2005 ;288:H111-5.

22.

Sanz-Rosa D. , Cediel E. , de las Heras N. et al. Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats: role of the NFkappaB/IkappaB system. J Hypertens 2005 ;23:1167-72.

23.

Schiffrin EL , Deng LY Structure and function of resistance arteries of hypertensive patients treated with a beta-blocker or a calcium channel antagonist. J Hypertens 1997;15:613-18.

24.

Thybo NK , Stwephens N. , Cooper A. , Aalkjaer C. , Heagerty AM , Mulvany MJ Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995;25:474-81.

25.

Ruiz-Ortega M. , Ruperez M. , Esteban V. , Egido J. Molecular Mechanisms of Angiotensin II-Induced Vascular Injury. Curr Hypertens Rep, 2003;5:73-9.

26.

Ruiz-Ortega M. , Esteban V. , Ruperez M. et al. Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr Opin Nephrol Hypertens 2006;15:159-66.

27.

Perbal B. CCN proteins: multifunctional signalling regulators. Lancet 2004;363;62-4.

28.

Bradham DM , Igarashi A. , Potter RL , Grotendorts GR Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991 ;114:1285-94.

29.

Rupérez M. , Lorenzo O. , Blanco-Colio LM , Esteban V. , Egido J. , Ruiz-Ortega M. The Connective Tissue Growth Factor is a Mediator of Angiotensin II-induced fibrosis. Circulation 2003;108:1499-509.

30.

Rupérez M. , Ruiz-Ortega M. , Esteban V. , Lorenzo O. , Mezzano S. , Plaza JJ , Egido J. Angiotensin II increases connective tissue growth factor in the kidney . Am J Pathol 2003;163:1937-47.

31.

Cachofeiro V. , Maeso R. , Rodrigo E. , Navarro J. , Ruilope LM , Lahera V. Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension . Hypertension 1995;26:236-43.

32.

Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques 1993;15:532-7.

33.

de las Heras N. , Aragoncillo P. , Maeso R. AT1-receptor antagonism reduces endothelial dysfunction and intimal thickening in atherosclerotic rabbits. Hypertension 1999;34:969-75.

34.

Schiffrin EL Remodelling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 2004;17:1192-200.

35.

Schiffrin EL Effect of antihypertensive treatment on small artery remodelling in hypertension. Can J Physiol Pharmacol 2003;81:168-76.

36.

Mombouli JV , Vanhoutte PM Endothelial Dysfunction: From Physiology to Therapy. J Mol Cell Cardiol 1999;31:61-74.

37.

Finckenberg P. , Lassila M. , Inkinen K. et al. Cyclosporine induces myocardial connective tissue growth factor in spontaneously hypertensive rats on high-sodium diet . Transplantation 2001;71:951-8.

38.

Dean RG , Balding LC , Candido R. et al. Connective tissue growth factor and cardiac fibrosis after myocardial infarction. J Histochem Cytochem 2005;53:1245-56.

39.

Gupta S. , Clarkson MR , Duggan J. , Brady HR Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 2000 ;58:1389-99.

40.

Ito Y. , Aten J. , Bende RJ et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998;53:853-61.

41.

Fan WH , Pech M. , Karnovsky MJ Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro. Eur J Cell Biol 2000;79:915-23.

42.

Hishikawa K. , Oemar BS , Tanner FC , Nakaki T. , Fujii T. , Luscher TF Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells. Circulation 1999;100:2108-12.

43.

Schild C. , Trueb B. Mechanical stress is required for high-level expression of connective tissue growth factor. Exp Cell Res 2002;274:83-91.

44.

Welch WJ , Wilcox CS AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int 2001 ;59:1257-63.

45.

Williams B. Angiotensin II and the pathophysiology of cardiovascular remodelling. Am J Cardiol. 2001;87:10C-7.

46.

Franklin TJ Therapeutic approaches to organ fibrosis. Int J Biochem Cell Biol 1997;29:79-89.

47.

Iwanciw D. , Rehm M. , Porst M. , Goppelt-Struebe M. Induction of connective tissue growth factor by angiotensin II: integration of signaling pathways. Arterioscler Thromb Vasc Biol 2003;23:1782-7.

48.

Rodriguez-Vita J. , Sanchez-Lopez E. , Esteban V. , Ruperez M. , Egido J. , Ruiz-Ortega M. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation 2005;111:2509-17.

49.

Liu B. , Yu J. , Taylor E.L. , Zhou X. , Polgar P. Microarray and phosphokinase screenings leading to studies on ERK and JNK regulation of connective tissue growth factor expression by angiotensin II 1a and bradykinin B2 receptors in Rat1 fibroblasts. J Cell Biochem 2006;97:1104-20.

50.

Rupérez M. , Sánchez-López E. , Blanco-Colio LM et al. The Rho-kinase pathway regulates Ang II-induced renal damage . Kidney Int 2005;99:S39-45.

51.

Wang S. , Denichilo M. , Brubaker C. , Hirschberg R. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy . Kidney Int 2001;60:96-105.

52.

Finckenberg P. , Inkinen K. , Ahonen J. et al. Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Am J Pathol 2003;163:355-66.

53.

Bidani AK , Griffin KA Pathophysiology of hypertensive renal damage: implications for therapy . Hypertension 2004;44:595-601.